| Market Cap | €109.0M | |
| Enterprise Value | — | |
| Revenue | €77.4M | −17.9% |
| Gross Profit | — | — |
| EBITDA | €14.1M | +151.9% |
| Net Income | €6.8M | — |
| Diluted EPS | €5.94 | — |
| Free Cash Flow | — | — |
| DPS (FY2021) | — |
| Trailing yield | — |
| Payout ratio | 2.7% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20212021-12-31 | — | — | reported |
| FY20202020-12-31 | — | — | reported |
| Ratio | 2020 | 2021 | Trend · 2y | vs own |
|---|---|---|---|---|
| ▾Margins | ||||
| Operating Margin | −7.15% | 0.67% | 75% | |
| EBITDA Margin | 5.94% | 18.23% | 75% | |
| NOPAT Margin | −5.65% | 0.53% | 75% | |
| Net Margin | −12.48% | 8.77% | 75% | |
| OCF Margin | 9.90% | 11.27% | 75% | |
| ▸Returns on Capital · 3 ratios | ||||
| ▸DuPont factors (ROE drivers) · 3 ratios | ||||
| ▸Earnings quality · 3 ratios | ||||
| ▸Liquidity & coverage · 3 ratios | ||||
| ▸Working capital · 3 ratios | ||||
| ▸Capital allocation · 3 ratios | ||||
| ▸Other · 1 ratios | ||||
| Line | 2020 | 2021 |
|---|---|---|
| Revenue | €94.2M | €77.4M |
| YoY % | -17.9% | |
| Operating Income | -€6.7M | €519,000 |
| Equity Method Income | -€2.2M | €549,000 |
| Pretax Income | -€12.1M | -€2.9M |
| Income Tax | -€1.0M | -€2.0M |
| Net Income (incl. NCI) | -€11.1M | -€909,000 |
| Minority Interest (P&L) | €688,000 | -€7.7M |
| Net Income | -€11.8M | €6.8M |
| EPS (Basic) | -€10.30 | €5.94 |
| EPS (Diluted) | -€10.30 | €5.94 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
